SQUAWK/NEWS
Menu
Live News EQUITY L impact

Avalo Therapeutics Files SEC Form

Avalo Therapeutics submits regulatory filing with the SEC. The filing is available for public review.

AVTX

Filed: 2026-05-26 AccNo: 0002047607-26-000004 Size: 5 KB